{"id":614477,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2014-12-05] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T01:41:05.362000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-6.html","snippet":"Notice - Prescription Drug List (PDL): Multiple additions December 5, 2014 Our file number: 14-115019-499 The purpose of this Notice of Amendment is to notify the addition of Agalsidase Beta, Apremilast, Azelastine, Basedoxifene, Ibrutinib and Ledispasvir to both the Human and…","rawSnapshotUrl":"/api/snapshots/raw/614477","browseUrl":"https://replay.healtharchive.ca/job-6/20260302014105/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-6.html#ha_snapshot=614477","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}